Suchen
Universe Pharmaceuticals Inc
UPCZur Watchlist hinzufügen
6.320USD
+0.760+13.67%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
3.56MMarktkapitalisierung
0.00KGV TTM
mehr Informationen über Universe Pharmaceuticals Inc Unternehmen
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
Universe Pharmaceuticals Inc Informationen
BörsenkürzelUPC
Name des UnternehmensUniverse Pharmaceuticals Inc
IPO-datumMar 23, 2021
CEOLai (Gang)
Anzahl der mitarbeiter225
WertpapierartOrdinary Share
GeschäftsjahresendeMar 23
Addresse265 Jingjiu Avenue
StadtJI'AN
BörseNASDAQ OMX - NASDAQ BASIC
LandChina
Postleitzahl343100
Telefon867968403309
Websitehttp://www.universe-pharmacy.com/
BörsenkürzelUPC
IPO-datumMar 23, 2021
CEOLai (Gang)
Führungskräfte von Universe Pharmaceuticals Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
71.89K
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--
Ms. Tina Xiao
Ms. Tina Xiao
IR Contact Officer
IR Contact Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
71.89K
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Universe Pharmaceuticals Inc?
Die fünf größten Anteilseigner von Universe Pharmaceuticals Inc sind: Mr. Gang Lai
Wie viele Institutionen halten Anteile an Universe Pharmaceuticals Inc (UPC)?
Mit Stand vom 2026Q1 halten 15 Institutionen Anteile an Universe Pharmaceuticals Inc, mit einem Gesamtmarktwert von etwa 28.11K, was 5.02% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 18652.00 gestiegen.
Was ist die größte Einnahmequelle von Universe Pharmaceuticals Inc?
Am 2026Q1 erzielte das Geschäft mit Sales of TCMD products für Universe Pharmaceuticals Inc den höchsten Umsatz in Höhe von 13.26M, was 74.25% des Gesamtumsatzes entspricht.